Plasma basic fibroblast growth factor and bone marrow fibrosis in clonal myeloproliferative disorders

Clinical and Laboratory Haematology

Volumn 26, Issue 4, 2004, Pages 265-268

  Sayinalp, N ^a,b   Cinar H ^a   Uner A ^a   Haznedaroglu I C ^a   Buyukasik Y ^a   Goker H ^a   Aksu, S ^a   Ozcebe O I ^a   Karakus S ^a   Kirazli, S ^a   Dundar S V ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Basic fibroblast growth factor; Myelodysplastic syndrome; Myelofibrosis; Myeloproliferative disorders

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BONE MARROW; BONE MARROW BIOPSY; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROSIS; HEMATOPOIESIS; HISTOPATHOLOGY; HUMAN; MALE; MYELODYSPLASTIC SYNDROME; MYELOFIBROSIS; MYELOID METAPLASIA; MYELOPROLIFERATIVE DISORDER; PLASMA; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REFRACTORY ANEMIA; THROMBOCYTHEMIA;

ADULT; AGED; BONE MARROW EXAMINATION; CLONE CELLS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDERS; REFERENCE VALUES;

EID: 4043050888     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2004.00616.x     Document Type: Article

References (28)

1. Aguayo A., Kantarjian H., Manshouri T., Gidel C., Estey E., Thomas D., Koller C., Estrov Z., O'Brien S., Keating M., Freireich E. & Albitar M. (2000) Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 96, 2240-2245.
2. Albitar M. (2001) Angiogenesis in acute myeloid leukemia and myelodysplastic syndrome. Acta Haematologica 106, 170-176.
3. Avraham H., Banu N., Scadden D.T., Abraham J. & Groopman J.E. (1994) Modulation of megakaryocytopoiesis by human basic fibroblast growth factor. Blood 83, 2126-2132.
4. Bousse-Kerdiles M.C., Chevillard S., Charpentier A., Romquin N., Clay D., Smadja-Joffe F., Praloran V., Dupriez B., Demory J.L., Jasmin C. & Martyre M.C. (1996) Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 88, 4534-4546.
5. Brunner G., Nguyen H., Gabrilove J., Rifkin D.B. & Wilson E.L. (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 81, 631-638.
6. Bruno E., Cooper R.J., Wilson E.L., Gabrilove J.L & Hoffman R. (1993) Basic fibroblast growth factor promotes the proliferation of human megakaryocyte progenitor cells. Blood 82, 430-435.
7. Burchill S.A. & Westwood G. (2002) Mechanism of basic fibroblast growth factor-induced cell death. Apoptosis 7, 5-12.
8. Burger P.E., Lukey P.T., Coetzee S. & Wilson E.L. (2002) Basic fibroblast growth factor modulates the expression of glycophorin A and c-kit and inhibits erythroid differentiation in K562 cells. Journal of Cellular Physiology 190, 83-91.
9. Giles F.J., Cooper M.A., Silverman L., Karp J.E., Lancet J.E., Zangari M., Shami P.J., Khan K.D., Hannah A.L., Cherrington J.M., Thomas D.A., Garcia-Manero G., Albitar M., Kantarjian K.M. & Stopeck A.T. (2003) Phase II study of SU5416-a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor-in patients with refractory myeloproliferative diseases. Cancer 97, 1920-1928.
10. Hasebe T., Imoto S., Ogura T. & Mukai K. (1997) Significance of basic fibroblast growth factor and fibroblast growth factor receptor protein expression in the formation of fibrotic focus in invasive ductal carcinoma of the breast. Japanese Journal of Cancer Research 88, 877-885.
11. Hasselbalch H.C. (2003) SU6668 in idiopathic myelofibrosis-a rational therapeutic approach targeting several tyrosine kinases of importance for the myeloproliferation and the development of bone marrow fibrosis and angiogenesis. Medical Hypotheses 61, 244-247.
12. Hasselbalch H., Junker P., Lisse I., Lindqvist U. & Engstrom L.A. (1991) Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders. American Journal of Hematology 36, 1-8.
13. Inoue Y., King T.E. Jr, Barker E., Daniloff E. & Newman L.S. (2002) Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. American Journal of Respiratory and Critical Care Medicine 166, 765-773.
14. Li C.Y. (2002) The role of morphology, cytochemistry and immunohistochemistry in the diagnosis of chronic myeloproliferative diseases. International Journal of Hematology 76(Suppl. 2), 6-8.
15. Mandriota S.J. & Pepper M.S. (1997) Vascular endothelial growth factor-induced in vitro angiogenesis and plasminogen activator expression are dependent on endogenous basic fibroblast growth factor. Journal of Cell Science 110, 2293-2302.
16. Martyre M.C., Bousse-Kerdiles M.C., Romquin N., Chevillard S., Praloran V., Demory J.L. & Dupriez B. (1997) Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis. British Journal of Haematology 97, 441-448.
17. Maschek H., Georgii A., Kaloutsi V., Werner M., Bandecar K., Kressel M.G., Choritz H., Freund M. & Hufnagl D. (1992) Myelofibrosis in primary myelodysplastic syndromes: a retrospective study of 352 patients. European Journal of Haematology 48, 208-214.
18. Mignatti P. & Rifkin D.B. (1991) Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? Journal of Cellular Biochemistry 47, 201-207.
19. Musolino C., Calabro' L., Bellomo G., Martello F., Loteta B., Pezzano C., Rizzo V. & Alonci A. (2002) Soluble angiogenic factors: implications for chronic myeloproliferative disorders. American Journal of Hematology 69, 159-163.
20. Ohshima K., Sugihara M., Suzumiya J., Haraoka S., Kanda M., Shimazaki K., Katoh K., Kumagawa M. & Kikuchi M. (1999) Basic fibroblast growth factor and fibrosis in Hodgkin's disease. Pathology, Research and Practice 195, 149-155.
21. Orpana A. & Salven P. (2002) Angiogenic and lymphangiogenic molecules in hematological malignancies. Leukemia and Lymphoma 43, 219-224.
22. Reilly J.T. (1997) Idiopathic myelofibrosis: pathogenesis, natural history and management. Blood Reviews 11, 233-242.
23. Vergilio J.A. & Bagg A. (2003) Myelodysplastic syndromes. Contemporary biologic concepts and emerging diagnostic approaches. American Journal of Clinical Pathology 119(Suppl.), S58-S77.
24. Wehmeier A. & Sudhoff T. (1997) Elevated plasma levels of basic fibroblast growth factor in patients with essential thrombocythaemia and polycythaemia vera. British Journal of Haematology 98, 1050-1051.
25. Wilson E.L., Rifkin D.B., Kelly F., Hannocks M.J. & Gabrilove J.L. (1991) Basic fibroblast growth factor stimulates myelopoiesis in long-term human bone marrow cultures. Blood 77, 954-960.
26. Yoon S.Y., Tefferi A. & Li C.Y. (2000) Cellular distribution of platelet-derived growth factor, transforming growth factorbeta, basic fibroblast growth factor, and their receptors in normal bone marrow. Acta Haematologica 104, 151-157.
27. Yoon S.Y., Li C.Y., Lloyd R.V. & Tefferi A. (2000) Bone marrow histochemical studies of fibrogenic cytokines and their receptors in myelodysplastic syndrome with myelofibrosis and related disorders. International Journal of Hematology 72, 337-342.
28. Yoon S.Y., Tefferi A. & Li C.Y. (2001) Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders. Haematologica 86, 52-57.